Slow intraventricular delivery
US11253485B2 · kind B2 · utility
3Cited by
10References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2019 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Feb 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Neurological diseases, including lysosomal storage diseases, can be successfully treated using intraventricular delivery of the therapeutic agents to bypass the blood-brain barrier. Similarly, diagnostic agents and anesthetic agents can be delivered to the brain in this manner. The administration can be performed slowly to achieve maximum effect. Such administration permits greater penetration of distal portions of the brain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.